Successful Treatment of Nivolumab-Resistant Multiple In-Transit Melanomas with Ipilimumab and Topical Imiquimod

Successful Treatment of Nivolumab-Resistant Multiple In-Transit Melanomas with Ipilimumab and Topical Imiquimod

Simultaneous or sequential, planned administration of ipilimumab could significantly enhance the antitumor effects of nivolumab in advanced melanoma patients. On the other hand, the efficacy of ipilimumab for nivolumab-resistant advanced melanoma is extremely poor. Therefore, additional supportive t...

Full description

Bibliographic Details
Main Authors: Taku Fujimura, Yumi Kambayashi, Yota Sato, Kayo Tanita, Sadanori Furudate, Akira Tsukada, Hisayuki Tono, Akira Hashimoto, Setsuya Aiba
Format: Article
Language:English
Published: Karger Publishers 2018-01-01
Series:Case Reports in Oncology
Subjects:
Nivolumab-resistant melanoma
Ipilimumab
Imiquimod
Online Access:https://www.karger.com/Article/FullText/485612

Internet

https://www.karger.com/Article/FullText/485612

Similar Items